Copyright © 2012 Yazi D. Ke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. M. Goedert and M. G. Spillantini, “A century of Alzheimer's disease,” Science, vol. 314, no. 5800, pp. 777–781, 2006. View at Publisher · View at Google Scholar · View at Scopus
2. K. R. Brunden, J. Q. Trojanowski, and V. M. Y. Lee, “Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies,” Nature Reviews Drug Discovery, vol. 8, no. 10, pp. 783–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
3. L. M. Ittner and J. Götz, “Amyloid-β and tau—a toxic pas de deux in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 12, no. 2, pp. 67–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
4. C. Haass, M. G. Schlossmacher, A. Y. Hung et al., “Amyloid β-peptide is produced by cultured cells during normal metabolism,” Nature, vol. 359, no. 6393, pp. 322–325, 1992. View at Publisher · View at Google Scholar · View at Scopus
5. C. L. Masters, G. Simms, N. A. Weinman, et al., “Amyloid plaque core protein in Alzheimer disease and Down syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 12, pp. 4245–4249, 1985. View at Scopus
6. H. W. Querfurth and F. M. LaFerla, “Alzheimer's disease,” The New England Journal of Medicine, vol. 362, no. 4, pp. 329–344, 2010. View at Publisher · View at Google Scholar · View at Scopus
7. N. J. Cairns, E. H. Bigio, I. R. A. Mackenzie et al., “Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration,” Acta Neuropathologica, vol. 114, no. 1, pp. 5–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
8. R. M. Liscic, L. T. Grinberg, J. Zidar, M. A. Gitcho, and N. J. Cairns, “ALS and FTLD: two faces of TDP-43 proteinopathy,” European Journal of Neurology, vol. 15, no. 8, pp. 772–780, 2008. View at Publisher · View at Google Scholar · View at Scopus
9. I. R. A. MacKenzie, M. Neumann, E. H. Bigio et al., “Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update,” Acta Neuropathologica, vol. 119, no. 1, pp. 1–4, 2010. View at Publisher · View at Google Scholar · View at Scopus
10. L. Bertram and R. E. Tanzi, “The genetic epidemiology of neurodegenerative disease,” The Journal of Clinical Investigation, vol. 115, no. 6, pp. 1449–1457, 2005. View at Publisher · View at Google Scholar · View at Scopus
11. S. S. Sisodia and P. H. St George-Hyslop, “γ-secretase, Notch, Aβ and Alzheimer's disease: where do the presenilins fit in?” Nature Reviews Neuroscience, vol. 3, no. 4, pp. 281–290, 2002. View at Publisher · View at Google Scholar · View at Scopus
12. M. G. Spillantini, J. R. Murrell, M. Goedert, M. R. Farlow, A. Klug, and B. Ghetti, “Mutation in the tau gene in familial multiple system tauopathy with presenile dementia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7737–7741, 1998. View at Publisher · View at Google Scholar · View at Scopus
13. M. Hutton, C. L. Lendon, P. Rizzu et al., “Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17,” Nature, vol. 393, no. 6686, pp. 702–705, 1998. View at Publisher · View at Google Scholar · View at Scopus
14. M. D. Weingarten, A. H. Lockwood, S. Y. Hwo, and M. W. Kirschner, “A protein factor essential for microtubule assembly,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 5, pp. 1858–1862, 1975. View at Scopus
15. M. Goedert, C. M. Wischik, R. A. Crowther, J. E. Walker, and A. Klug, “Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 11, pp. 4051–4055, 1988. View at Scopus
16. M. Goedert, M. G. Spillantini, R. Jakes, D. Rutherford, and R. A. Crowther, “Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease,” Neuron, vol. 3, no. 4, pp. 519–526, 1989. View at Scopus
17. S. Chen, K. Townsend, T. E. Goldberg, P. Davies, and C. Conejero-Goldberg, “MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variants,” Journal of Alzheimer's Disease, vol. 22, no. 4, pp. 1313–1329, 2010. View at Publisher · View at Google Scholar · View at Scopus
18. I. D'Souza and G. D. Schellenberg, “Regulation of tau isoform expression and dementia,” Biochimica et Biophysica Acta, vol. 1739, no. 2-3, pp. 104–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
19. G. Lee, N. Cowan, and M. Kirschner, “The primary structure and heterogeneity of tau protein from mouse brain,” Science, vol. 239, no. 4837, pp. 285–288, 1988. View at Scopus
20. R. Brandt, J. Léger, and G. Lee, “Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain,” Journal of Cell Biology, vol. 131, no. 5, pp. 1327–1340, 1995. View at Publisher · View at Google Scholar · View at Scopus
21. B. Trinczek, A. Ebneth, E. M. Mandelkow, and E. Mandelkow, “Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles,” Journal of Cell Science, vol. 112, part 14, pp. 2355–2367, 1999. View at Scopus
22. R. Dixit, J. L. Ross, Y. E. Goldman, and E. L. F. Holzbaur, “Differential regulation of dynein and kinesin motor proteins by tau,” Science, vol. 319, no. 5866, pp. 1086–1089, 2008. View at Publisher · View at Google Scholar · View at Scopus
23. J. Z. Wang and F. Liu, “Microtubule-associated protein tau in development, degeneration and protection of neurons,” Progress in Neurobiology, vol. 85, no. 2, pp. 148–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
24. L. M. Ittner, Y. D. Ke, F. Delerue et al., “Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models,” Cell, vol. 142, no. 3, pp. 387–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
25. M. Goedert, M. G. Spillantini, N. J. Cairns, and R. A. Crowther, “Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms,” Neuron, vol. 8, no. 1, pp. 159–168, 1992. View at Publisher · View at Google Scholar · View at Scopus
26. A. C. Alonso, I. Grundke-Iqbal, and K. Iqbal, “Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules,” Nature Medicine, vol. 2, no. 7, pp. 783–787, 1996. View at Publisher · View at Google Scholar · View at Scopus
27. B. R. Hoover, M. N. Reed, J. Su et al., “Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration,” Neuron, vol. 68, no. 6, pp. 1067–1081, 2010. View at Publisher · View at Google Scholar · View at Scopus
28. J. Gotz, A. Probst, M. G. Spillantini et al., “Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform,” The EMBO Journal, vol. 14, no. 7, pp. 1304–1313, 1995. View at Scopus
29. K. Santacruz, J. Lewis, T. Spires et al., “Tau suppression in a neurodegenerative mouse model improves memory function,” Science, vol. 309, no. 5733, pp. 476–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
30. J. van Eersel, M. Bi, Y. D. Ke et al., “Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains,” Journal of Neural Transmission, vol. 116, no. 10, pp. 1243–1251, 2009. View at Publisher · View at Google Scholar · View at Scopus
31. K. Stamer, R. Vogel, E. Thies, E. Mandelkow, and E. M. Mandelkow, “Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress,” Journal of Cell Biology, vol. 156, no. 6, pp. 1051–1063, 2002. View at Publisher · View at Google Scholar · View at Scopus
32. T. Ishihara, M. Hong, B. Zhang et al., “Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform,” Neuron, vol. 24, no. 3, pp. 751–762, 1999. View at Scopus
33. L. M. Ittner, T. Fath, Y. D. Ke et al., “Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 41, pp. 15997–16002, 2008. View at Publisher · View at Google Scholar · View at Scopus
34. L. M. Ittner, Y. D. Ke, and J. Götz, “Phosphorylated tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease,” The Journal of Biological Chemistry, vol. 284, no. 31, pp. 20909–20916, 2009. View at Publisher · View at Google Scholar · View at Scopus
35. V. Rhein, X. Song, A. Wiesner et al., “Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 20057–20062, 2009. View at Publisher · View at Google Scholar · View at Scopus
36. D. C. David, S. Hauptmann, I. Scherping et al., “Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice,” The Journal of Biological Chemistry, vol. 280, no. 25, pp. 23802–23814, 2005. View at Publisher · View at Google Scholar · View at Scopus
37. J. Götz and L. M. Ittner, “Animal models of Alzheimer's disease and frontotemporal dementia,” Nature Reviews Neuroscience, vol. 9, no. 7, pp. 532–544, 2008. View at Publisher · View at Google Scholar · View at Scopus
38. A. Caceres and K. S. Kosik, “Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons,” Nature, vol. 343, no. 6257, pp. 461–463, 1990. View at Publisher · View at Google Scholar · View at Scopus
39. A. Harada, K. Oguchi, S. Okabe et al., “Altered microtubule organization in small-calibre axons of mice lacking tau protein,” Nature, vol. 369, no. 6480, pp. 488–491, 1994. View at Publisher · View at Google Scholar · View at Scopus
40. H. N. Dawson, A. Ferreira, M. V. Eyster, N. Ghoshal, L. I. Binder, and M. P. Vitek, “Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice,” Journal of Cell Science, vol. 114, no. 6, pp. 1179–1187, 2001. View at Scopus
41. K. L. Tucker, M. Meyer, and Y. A. Barde, “Neurotrophins are required for nerve growth during development,” Nature Neuroscience, vol. 4, no. 1, pp. 29–37, 2001. View at Publisher · View at Google Scholar · View at Scopus
42. K. Fujio, M. Sato, T. Uemura, T. Sato, R. Sato-Harada, and A. Harada, “14-3-3 proteins and protein phosphatases are not reduced in tau-deficient mice,” NeuroReport, vol. 18, no. 10, pp. 1049–1052, 2007. View at Publisher · View at Google Scholar · View at Scopus
43. S. Ikegami, A. Harada, and N. Hirokawa, “Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice,” Neuroscience Letters, vol. 279, no. 3, pp. 129–132, 2000. View at Publisher · View at Google Scholar · View at Scopus
44. P. Lei, S. Ayton, D. I. Finkelstein, et al., “Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export,” Nature Medicine, vol. 18, no. 2, pp. 291–295, 2012.
45. Y. Takei, J. Teng, A. Harada, and N. Hirokawa, “Defects axonal elongation and neuronal migration in mice with disrupted tau and map1b genes,” Journal of Cell Biology, vol. 150, no. 5, pp. 989–1000, 2000. View at Publisher · View at Google Scholar · View at Scopus
46. C. Andorfer, Y. Kress, M. Espinoza et al., “Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms,” Journal of Neurochemistry, vol. 86, no. 3, pp. 582–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
47. E. G. de Barreda, H. N. Dawson, M. P. Vitek, and J. Avila, “Tau deficiency leads to the upregulation of BAF-57, a protein involved in neuron-specific gene repression,” FEBS Letters, vol. 584, no. 11, pp. 2265–2270, 2010. View at Publisher · View at Google Scholar · View at Scopus
48. A. Ittner, Y. D. Ke, J. van Eersel, A. Gladbach, J. Götz, and L. M. Ittner, “Brief update on different roles of tau in neurodegeneration,” IUBMB Life, vol. 63, no. 7, pp. 495–502, 2011. View at Publisher · View at Google Scholar · View at Scopus
49. E. D. Roberson, K. Scearce-Levie, J. J. Palop et al., “Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model,” Science, vol. 316, no. 5825, pp. 750–754, 2007. View at Publisher · View at Google Scholar · View at Scopus
50. H. N. Dawson, V. Cantillana, M. Jansen et al., “Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease,” Neuroscience, vol. 169, no. 1, pp. 516–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
51. J. L. Cantero, B. Moreno-Lopez, F. Portillo, A. Rubio, E. Hita-Yañez, and J. Avila, “Role of tau protein on neocortical and hippocampal oscillatory patterns,” Hippocampus, vol. 21, no. 8, pp. 827–834, 2011. View at Publisher · View at Google Scholar · View at Scopus
52. J. J. Palop and L. Mucke, “Amyloid-β—induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks,” Nature Neuroscience, vol. 13, no. 7, pp. 812–818, 2010. View at Publisher · View at Google Scholar · View at Scopus
53. J. L. Cantero, E. Hita-Yaez, B. Moreno-Lopez, F. Portillo, A. Rubio, and J. Avila, “Tau protein role in sleep-wake cycle,” Journal of Alzheimer's Disease, vol. 21, no. 2, pp. 411–421, 2010. View at Publisher · View at Google Scholar · View at Scopus
54. K. Duff, H. Knight, L. M. Refolo et al., “Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes,” Neurobiology of Disease, vol. 7, no. 2, pp. 87–98, 2000. View at Publisher · View at Google Scholar · View at Scopus
55. M. Polydoro, C. M. Acker, K. Duff, P. E. Castillo, and P. Davies, “Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology,” The Journal of Neuroscience, vol. 29, no. 34, pp. 10741–10749, 2009. View at Publisher · View at Google Scholar · View at Scopus
56. C. Andorfer, C. M. Acker, Y. Kress, P. R. Hof, K. Duff, and P. Davies, “Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms,” The Journal of Neuroscience, vol. 25, no. 22, pp. 5446–5454, 2005. View at Publisher · View at Google Scholar · View at Scopus
57. K. Ando, K. Leroy, C. Héraud et al., “Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model,” The American Journal of Pathology, vol. 178, no. 2, pp. 803–816, 2011. View at Publisher · View at Google Scholar · View at Scopus
58. K. Sennvik, K. Boekhoorn, R. Lasrado et al., “Tau-4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/knockout mice,” The FASEB Journal, vol. 21, no. 9, pp. 2149–2161, 2007. View at Publisher · View at Google Scholar · View at Scopus
59. H. Ding, P. J. Dolan, and G. V. W. Johnson, “Histone deacetylase 6 interacts with the microtubule-associated protein tau,” Journal of Neurochemistry, vol. 106, no. 5, pp. 2119–2130, 2008. View at Publisher · View at Google Scholar · View at Scopus
60. M. Perez, I. Santa-Maria, E. G. de Barreda et al., “Tau—an inhibitor of deacetylase HDAC6 function,” Journal of Neurochemistry, vol. 109, no. 6, pp. 1756–1766, 2009. View at Publisher · View at Google Scholar · View at Scopus
61. M. Hashiguchi, K. Sobue, and H. K. Paudel, “14-3-3ζ is an effector of tau protein phosphorylation,” The Journal of Biological Chemistry, vol. 275, no. 33, pp. 25247–25254, 2000. View at Publisher · View at Google Scholar · View at Scopus
62. A. Agarwal-Mawal, H. Y. Qureshi, P. W. Cafferty et al., “14-3-3 connects glycogen synthase kinase-3β to tau within a brain microtubule-associated tau phosphorylation complex,” The Journal of Biological Chemistry, vol. 278, no. 15, pp. 12722–12728, 2003. View at Publisher · View at Google Scholar · View at Scopus
63. Z. Yuan, A. Agarwal-Mawal, and H. K. Paudel, “14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3β in the brain,” The Journal of Biological Chemistry, vol. 279, no. 25, pp. 26105–26114, 2004. View at Publisher · View at Google Scholar · View at Scopus
64. F. Oyama, S. Kotliarova, A. Harada et al., “Gem GTPase and tau: morphological changes induced by gem GTPase in cho cells are antagonized by tau,” The Journal of Biological Chemistry, vol. 279, no. 26, pp. 27272–27277, 2004. View at Publisher · View at Google Scholar · View at Scopus
65. E. Battaglioli, M. E. Andrés, D. W. Rose et al., “Rest repression of neuronal genes requires components of the hSWI·SNF complex,” The Journal of Biological Chemistry, vol. 277, no. 43, pp. 41038–41045, 2002. View at Publisher · View at Google Scholar · View at Scopus
66. P. A. Loomis, T. H. Howard, R. P. Castleberry, and L. I. Binder, “Identification of nuclear tau isoforms in human neuroblastoma cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 21, pp. 8422–8426, 1990. View at Scopus
67. V. M. Lee, “Biomedicine. Tauists and beta-aptists united—well almost!,” Science, vol. 293, no. 5534, pp. 1446–1447, 2001.
68. J. Lewis, D. W. Dickson, W. L. Lin et al., “Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP,” Science, vol. 293, no. 5534, pp. 1487–1491, 2001. View at Publisher · View at Google Scholar · View at Scopus
69. J. Götz, F. Chen, J. van Dorpe, and R. M. Nitsch, “Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils,” Science, vol. 293, no. 5534, pp. 1491–1495, 2001. View at Publisher · View at Google Scholar · View at Scopus
70. M. Rapoport, H. N. Dawson, L. I. Binder, M. P. Vitek, and A. Ferreira, “Tau is essential to β-amyloid-induced neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 9, pp. 6364–6369, 2002. View at Publisher · View at Google Scholar · View at Scopus
71. J. J. Palop and L. Mucke, “Epilepsy and cognitive impairments in Alzheimer disease,” Archives of Neurology, vol. 66, no. 4, pp. 435–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
72. C. Haass and E. Mandelkow, “Fyn-tau-amyloid: a toxic triad,” Cell, vol. 142, no. 3, pp. 356–358, 2010. View at Publisher · View at Google Scholar · View at Scopus
73. E. D. Roberson, B. Halabisky, J. W. Yoo et al., “Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease,” The Journal of Neuroscience, vol. 31, no. 2, pp. 700–711, 2011. View at Publisher · View at Google Scholar · View at Scopus
74. J. Chin, J. J. Palop, J. Puoliväli et al., “Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease,” The Journal of Neuroscience, vol. 25, no. 42, pp. 9694–9703, 2005. View at Publisher · View at Google Scholar · View at Scopus
75. J. Chin, J. J. Palop, G. Q. Yu, N. Kojima, E. Masliah, and L. Mucke, “Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice,” The Journal of Neuroscience, vol. 24, no. 19, pp. 4692–4697, 2004. View at Publisher · View at Google Scholar · View at Scopus
76. O. A. Shipton, J. R. Leitz, J. Dworzak et al., “Tau protein is required for amyloid β-induced impairment of hippocampal long-term potentiation,” The Journal of Neuroscience, vol. 31, no. 5, pp. 1688–1692, 2011. View at Publisher · View at Google Scholar · View at Scopus
77. K. A. Vossel, K. Zhang, J. Brodbeck et al., “Tau reduction prevents Aβ-induced defects in axonal transport,” Science, vol. 330, no. 6001, article 198, 2010. View at Publisher · View at Google Scholar · View at Scopus
78. A. Yuan, A. Kumar, C. Peterhoff, K. Duff, and R. A. Nixon, “Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice,” The Journal of Neuroscience, vol. 28, no. 7, pp. 1682–1687, 2008. View at Publisher · View at Google Scholar · View at Scopus
79. J. Busciglio, A. Lorenzo, J. Yeh, and B. A. Yankner, “β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding,” Neuron, vol. 14, no. 4, pp. 879–888, 1995. View at Scopus
80. A. Ferreira, Q. Lu, L. Orecchio, and K. S. Kosik, “Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar Aβ,” Molecular and Cellular Neurosciences, vol. 9, no. 3, pp. 220–234, 1997. View at Publisher · View at Google Scholar · View at Scopus
81. E. G. de Barreda, M. Pérez, P. G. Ramos et al., “Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits,” Neurobiology of Disease, vol. 37, no. 3, pp. 622–629, 2010. View at Publisher · View at Google Scholar · View at Scopus
82. Y. Miao, J. Chen, Q. Zhang, and A. Sun, “Deletion of tau attenuates heat shock-induced injury in cultured cortical neurons,” Journal of Neuroscience Research, vol. 88, no. 1, pp. 102–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
83. A. Sultan, F. Nesslany, M. Violet et al., “Nuclear tau, a key player in neuronal DNA protection,” The Journal of Biological Chemistry, vol. 286, no. 6, pp. 4566–4575, 2011. View at Publisher · View at Google Scholar · View at Scopus
84. M. Morris, A. Koyama, E. Masliah, and L. Mucke, “Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease,” PLoS ONE, vol. 6, no. 12, Article ID e29257, 2011.
85. C. D. Pacheco, M. J. Elrick, and A. P. Lieberman, “Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis,” Human Molecular Genetics, vol. 18, no. 5, pp. 956–965, 2009. View at Publisher · View at Google Scholar · View at Scopus